Disease | intrahepatic cholangiocarcinoma |
Comorbidity | C0019204|hepatocellular carcinoma |
Sentences | 1 |
PubMedID- 22723030 | Recently, the aasld removed ceus from their guidelines in part because of the perceived possibility of false-positive hepatocellular carcinoma (hcc) diagnosis in patients with intrahepatic cholangiocarcinoma (icc), and in part because ceus is not available in the usa. |
Page: 1